A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Acquiring Traction Online
Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers market the drug there before redirecting buyers to other platforms for purchases.
Learning About Retatrutide
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and chemists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users administering products of uncertain source.
Several professionals said the popularity for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.
Some influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and consumer laws, risking penalties, legal action or prison.
Service Reaction and Content Removal
According to TikTok, the platform has removed problematic content and prohibited related keywords and search suggestions. The organization said it was dedicated to keeping the platform safe and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Research also discovered communities with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, populated with photos of weight loss, positive testimonials and detailed guides for preparing or administering at home.
Within minutes of joining one community, a vendor shared WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.
Product Information and Costs
Inside these groups, posts display black plastic packages with postal service labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A representative for the messaging service said it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they cannot confirm. Although the research behind this drug is valid, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her staff has already seen patients injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company investigational product not yet approved … may expose users to possibly significant health risks”.
